{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-002862","form_type":"8-K","ticker":"BAX","cik":"0000010456","company_name":"BAXTER INTERNATIONAL INC","filed_at":"2023-02-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.649080+00:00","generated_at":"2026-06-19T19:06:40.893908+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Baxter reports Q4 sales $3.9B, full-year GAAP loss of $4.83 per share; spinoff update","bullets":["Q4 revenue $3.9B (+11% reported, +17% constant currency); GAAP EPS $0.36, adjusted EPS $0.88.","Full-year sales $15.1B (+18% reported); GAAP diluted EPS loss ($4.83); adjusted EPS $3.50.","Company reiterates plans to spin off Renal Care and Acute Therapies into a new kidney care company.","CEO cites ongoing macroeconomic and supply chain headwinds weighing on performance.","Guidance for 2023 provided in full press release; no specific numbers in excerpt."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-002862","json":"https://secwatch.observer/filing/0001628280-23-002862.json","markdown":"https://secwatch.observer/filing/0001628280-23-002862.md","text":"https://secwatch.observer/filing/0001628280-23-002862.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/10456/000162828023002862/0001628280-23-002862-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/10456/000162828023002862/bax-20230209.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T19:06:40.893908+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4ee3c1c58fa8f53ce308747ad8aa9ce83a0a22fa","claim":"BAXTER INTERNATIONAL INC reported financial results for the fourth quarter and full year ended Dec. 31, 2022.","evidence_excerpt":"On February 9, 2023 , Baxter International Inc. (the Company) issued an earnings press release for the period ended December 31, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/10456/000162828023002862/0001628280-23-002862-index.htm","confidence":0.8,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and full year ended Dec. 31, 2022"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}